Current and historical daily PE Ratio for Simcere Pharmaceutical Group Ltd (
HKSE:02096
) from 2020 to Jun 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Simcere Pharmaceutical Group stock (HKSE:02096) PE ratio as of Jun 20 2024 is 20.25.
More Details
Simcere Pharmaceutical Group Ltd (HKSE:02096) PE Ratio (TTM) Chart
Simcere Pharmaceutical Group Ltd (HKSE:02096) PE Ratio (TTM) Historical Data
View and export this data going back to 2020. Start your Free Trial
Total 900
- 1
- 2
- 3
- 4
- 5
- 6
- 10
| Simcere Pharmaceutical Group PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-20 | 20.3 | 2024-04-15 | 18.4 |
| 2024-06-19 | 20.3 | 2024-04-12 | 18.4 |
| 2024-06-18 | 20.3 | 2024-04-11 | 18.6 |
| 2024-06-17 | 20.9 | 2024-04-10 | 18.7 |
| 2024-06-14 | 20.1 | 2024-04-09 | 18.6 |
| 2024-06-13 | 20.3 | 2024-04-08 | 18.6 |
| 2024-06-12 | 20.2 | 2024-04-05 | 18.8 |
| 2024-06-11 | 20.7 | 2024-04-03 | 18.5 |
| 2024-06-07 | 20.9 | 2024-04-02 | 18.7 |
| 2024-06-06 | 21.3 | 2024-03-28 | 18.6 |
| 2024-06-05 | 21.6 | 2024-03-27 | 18.8 |
| 2024-06-04 | 21.8 | 2024-03-26 | 19.1 |
| 2024-06-03 | 21.5 | 2024-03-25 | 19.0 |
| 2024-05-31 | 20.6 | 2024-03-22 | 19.1 |
| 2024-05-30 | 20.0 | 2024-03-21 | 19.3 |
| 2024-05-29 | 20.3 | 2024-03-20 | 18.6 |
| 2024-05-28 | 20.3 | 2024-03-19 | 18.6 |
| 2024-05-27 | 20.0 | 2024-03-18 | 18.9 |
| 2024-05-24 | 19.7 | 2024-03-15 | 18.6 |
| 2024-05-23 | 20.5 | 2024-03-14 | 18.6 |
| 2024-05-22 | 20.4 | 2024-03-13 | 19.2 |
| 2024-05-21 | 19.9 | 2024-03-12 | 19.0 |
| 2024-05-20 | 20.2 | 2024-03-11 | 18.5 |
| 2024-05-17 | 20.2 | 2024-03-08 | 18.0 |
| 2024-05-16 | 19.9 | 2024-03-07 | 17.8 |
| 2024-05-14 | 20.0 | 2024-03-06 | 18.6 |
| 2024-05-13 | 20.3 | 2024-03-05 | 18.6 |
| 2024-05-10 | 20.4 | 2024-03-04 | 19.4 |
| 2024-05-09 | 20.4 | 2024-03-01 | 19.3 |
| 2024-05-08 | 20.2 | 2024-02-29 | 19.5 |
| 2024-05-07 | 20.0 | 2024-02-28 | 19.1 |
| 2024-05-06 | 20.0 | 2024-02-27 | 19.7 |
| 2024-05-03 | 19.9 | 2024-02-26 | 19.6 |
| 2024-05-02 | 20.0 | 2024-02-23 | 19.5 |
| 2024-04-30 | 18.9 | 2024-02-22 | 19.6 |
| 2024-04-29 | 18.9 | 2024-02-21 | 19.4 |
| 2024-04-26 | 18.6 | 2024-02-20 | 19.2 |
| 2024-04-25 | 18.4 | 2024-02-19 | 18.9 |
| 2024-04-24 | 18.4 | 2024-02-16 | 19.4 |
| 2024-04-23 | 18.3 | 2024-02-15 | 18.3 |
| 2024-04-22 | 18.3 | 2024-02-14 | 18.6 |
| 2024-04-19 | 18.1 | 2024-02-09 | 18.4 |
| 2024-04-18 | 18.2 | 2024-02-08 | 18.7 |
| 2024-04-17 | 18.1 | 2024-02-07 | 18.4 |
| 2024-04-16 | 18.0 | 2024-02-06 | 18.7 |
Simcere Pharmaceutical Group Ltd (HKSE:02096) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Simcere Pharmaceutical Group Ltd
ISIN : HK0000658531
Share Class Description:
HKSE:02096: Ordinary SharesCompare
Compare
Traded in other countries / regions
02096.Hong KongS2P.GermanySMHGF.USA IPO Date
2020-10-27Description
Simcere Pharmaceutical Group Ltd is engaged in the R&D, production, and commercialization of pharmaceuticals focused on generic pharmaceuticals. It has a diversified product portfolio focused on therapeutic areas, including, oncology (including cell therapy), nervous system diseases, autoimmune diseases, and antiinfection. The company's products include Endostar, Enweida, Iremod, Sanbexin and Others.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers